Cetrorelix
Back to searchMolecule Structure
Scientific Name
Cetrorelix
Description of the Drug
Cetrorelix is a synthetic peptide antagonist of gonadotropin releasing hormone used to prevent luteinizing hormone surges in women undergoing assisted reproduction therapy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00050
http://www.drugbank.ca/drugs/DB00050
Brand Name(s)
Cetrotide
Company Owner(s)
Emd Serono Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Gonadotropin-releasing hormone receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1855 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL61331 | SCHEMBL19712202 | |
| Human Metabolome Database | HMDB0014261 | ||
| WDI | SB-75 | ||
| DrugBank | DB00050 | ||
| PubChem: Thomson Pharma | 14768541 | 14842112 | |
| PubChem | 25074887 | ||
| Nikkaji | J389.231J | ||
| EPA CompTox Dashboard | DTXSID7040996 | ||
| DrugCentral | 583 | ||
| ChemicalBook | CB9874701 | CB0316370 | |
| Guide to Pharmacology | 1190 | ||
| GSRS | 5ee5c618-3b32-4a9a-9a62-b4026fc16717 | ||
| rxnorm | CETROTIDE | CETRORELIX ACETATE | CETRORELIX |
| ChEBI | 59224 |
